Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

Bridging the gap: helping physicians make a difference

What can be done to help physicians make a difference? Diane Freeman highlights how marketers need to encourage physicians to make connections with their patients and she explains how. Three months ago, I had a strange experience at an appointment with a new physician. After a brief consultation, the doctor recommended...

Articles

Viewpoint: pharma industry myths

Anthony Walker shares his views on the future growth of the industry. Is radical innovation the only route to salvation? Amidst the voluminous commentaries, blogs, tweets, panels and papers about the future of the pharma industry, in some circles certain thoughts seem to be...

Articles

Pharma gets social: five keys to effective corporate bloggin...

Daniel Ghinn continues his series reviewing social media activity in pharma with a look at J&J’s corporate blog - JNJBTW. JNJBTW, Johnson & Johnson’s corporate blog, was one of the company’s early exploits into social media when it launched in 2007 and is …

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.